Pangea Natural Foods Acquires Amino Innovations: A Game-Changer in Peptide Therapies
Vancouver, BC – March 25, 2025 – Pangea Natural Foods Inc. (CSE: PNGA) (OTCQB: PNGAF), a leading manufacturer and co-packer of health food products and supplements, has announced the acquisition of 100% of the shares of Amino Innovations Corp. (“Amino”) on March 21, 2025. Amino is a pioneering company focused on advancing health and wellness through innovative peptide therapies and effective delivery systems.
About Amino Innovations
Amino is a newly formed corporation with a mission to revolutionize the health and wellness industry by providing consumers with cutting-edge peptide therapies. Their product line includes peptide formulations designed for various health concerns such as stress management, gut health, longevity, hair health, skin repair, and sleep health. Amino’s commitment to research and development has led them to the brink of creating needleless peptide delivery systems, making them a potential world leader in this field.
The Impact on Consumers
With Pangea’s acquisition of Amino, consumers can expect to see a wide range of innovative peptide therapies hitting the market. These therapies will offer effective solutions for various health concerns, allowing consumers to take control of their wellness journey. The development of needleless peptide delivery systems will make these therapies even more accessible, as they eliminate the need for invasive injections.
- Increased access to innovative peptide therapies
- More convenient delivery systems (needleless)
- Improved health and wellness solutions
The Impact on the World
The acquisition of Amino by Pangea marks a significant milestone in the health and wellness industry. This move will pave the way for the development and commercialization of needleless peptide therapies, which could potentially disrupt traditional healthcare systems. The potential benefits of these therapies extend beyond individual health, as they could help reduce the burden on healthcare systems and lower overall healthcare costs.
- Disruption of traditional healthcare systems
- Reduction in healthcare costs
- Improved access to innovative health solutions
Conclusion
The acquisition of Amino Innovations by Pangea Natural Foods is a game-changer in the health and wellness industry. This move will allow consumers to access innovative peptide therapies through more convenient delivery systems, ultimately improving their overall health and wellness. Additionally, the potential development of needleless peptide therapies could disrupt traditional healthcare systems and lower overall healthcare costs. As Pangea and Amino continue to push the boundaries of innovation, consumers can look forward to a future filled with accessible and effective health solutions.
Stay tuned for more updates on this exciting development!
